Activation of glucagon‐like peptide‐1 receptors in the nucleus accumbens attenuates cocaine seeking in rats
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Recent evidence indicates that activation of glucagon‐like peptide‐1 (GLP‐1) receptors reduces cocaine‐mediated behaviors and cocaine‐evoked dopamine release in the nucleus accumbens (NAc). However, no studies have examined the role of NAc GLP‐1 receptors in the reinstatement of cocaine‐seeking behavior, an animal model of relapse. Here, we show that systemic infusion of a behaviorally relevant dose of the GLP‐1 receptor agonist exendin‐4 penetrated the brain and localized with neurons and astrocytes in the NAc. Administration of exendin‐4 directly into the NAc core and shell subregions significantly attenuated cocaine priming‐induced reinstatement of drug‐seeking behavior. These effects were not due to deficits in operant responding or suppression of locomotor activity as intra‐accumbal exendin‐4 administration had no effect on sucrose‐seeking behavior. To determine the effects of GLP‐1 receptor activation on neuronal excitability, exendin‐4 was bath applied to ex vivo NAc slices from cocaine‐experienced and saline‐experienced rats following extinction of cocaine‐taking behavior. Exendin‐4 increased the frequency of action potential firing of NAc core and shell medium spiny neurons in cocaine‐experienced rats while no effect was observed in saline controls. In contrast, exendin‐4 did not affect the frequency or amplitude of spontaneous excitatory postsynaptic currents or alter the paired‐pulse ratios of evoked excitatory postsynaptic currents. These effects were not associated with altered expression of GLP‐1 receptors in the NAc following cocaine self‐administration. Taken together, these findings indicate that increased activation of GLP‐1 receptors in the NAc during cocaine abstinence increases intrinsic, but not synaptic, excitability of medium spiny neurons and is sufficient to reduce cocaine‐seeking behavior.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and addiction: Neurobiological overlaps
Volkow, N. D., Wang, G. ‐., Tomasi, D., & Baler, R. D. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01031.x · Cited by 800 · cited 2×
“…neural mechanisms and circuits mediating the reinforcing effects of palatable food and drugs of abuse (Narayanan, Guarnieri & DiLeone 2010; Kenny 2011; Volkow et al. 2013), it is likely that activation of central GLP-1 receptors also reduces voluntary cocaine-taking and cocaineseeking behaviors.”
BackgroundAlhadeff, A. L., Rupprecht, L. E., & Hayes, M. R. (2012) · Endocrinology · doi:10.1210/en.2011-1443 · Cited by 515 · cited 7×
“025 μg, which produced a transient effect on food intake following activation of GLP-1 receptors in the NAc core and no effect on food intake when infused into the NAc shell (Alhadeff et al. 2012).”
BackgroundMethodResultInfluentialDickson, S. L., Shirazi, R. H., Hansson, C., Bergquist, F., Nissbrandt, H., & Skibicka, K. P. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6326-11.2012 · Cited by 414 · cited 8×
“1 μg when infused into the NAc do not affect operant responding for sucrose or chow intake (Dickson et al. 2012).”
BackgroundResultInfluentialCommon cellular and molecular mechanisms in obesity and drug addiction
Kenny, P. J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3105 · Cited by 382
Kanoski, S. E., Rupprecht, L. E., Fortin, S. M., De Jonghe, B. C., & Hayes, M. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.022 · Cited by 273 · cited 4×
“2014) or produce aversive malaise-like effects (Hayes et al. 2011; Dickson et al. 2012; Kanoski et al. 2012).”
BackgroundResultInfluentialGLP-1 acts on habenular avoidance circuits to control nicotine intake
Tuesta, L. M., Chen, Z., Duncan, A., Fowler, C. D., Ishikawa, M., Lee, B. R., Liu, X.-A., Lu, Q., Cameron, M., Hayes, M. R., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4540 · Cited by 200
Real-time trafficking and signaling of the glucagon-like peptide-1 receptor
Roed, S. N., Wismann, P., Underwood, C. R., Kulahin, N., Iversen, H., Cappelen, K. A., Schäffer, L., Lehtonen, J., Hecksher-Soerensen, J., Secher, A., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.11.010 · Cited by 153
Schmidt, H. D., Mietlicki-Baase, E. G., Ige, K. Y., Maurer, J. J., Reiner, D. J., Zimmer, D. J., Van Nest, D. S., Guercio, L. A., Wimmer, M. E., Olivos, D. R., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.362 · Cited by 148 · cited 6×
“Immunohistochemistry was performed on free-floating coronal sections containing the NAc according to modified procedures from previously published studies (Reiner et al. 2016; Schmidt et al. 2016).”
BackgroundMethodSelf-citationSuchankova, P., Yan, J., Schwandt, M. L., Stangl, B. L., Caparelli, E. C., Momenan, R., Jerlhag, E., Engel, J. A., Hodgkinson, C. A., Egli, M., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.68 · Cited by 146
Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance
Reiner, D. J., Mietlicki-Baase, E. G., McGrath, L. E., Zimmer, D. J., Bence, K. K., Sousa, G. L., Konanur, V. R., Krawczyk, J., Burk, D. H., Kanoski, S. E., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3579-15.2016 · Cited by 133 · cited 2×
“In addition to binding GLP-1 receptors in vitro and in vivo, fluoro-Ex-4 produces behavioral responses identical to unlabeled exendin-4 (Rajan et al. 2015; Reiner et al. 2016).”
BackgroundMethod
Research works printed but not linked: 26
- 10.1523/JNEUROSCI.1607-04.2004 · DOI · Paper page
- 10.1152/ajpendo.00137.2013 · DOI · Paper page
- 10.1371/journal.pone.0069010 · DOI · Paper page
- 10.1007/s40263-014-0178-y · DOI · Paper page
- 10.1016/j.physbeh.2017.03.019 · DOI · Paper page
- 10.1038/mp.2012.141 · DOI · Paper page
- 10.1152/jn.00217.2004 · DOI · Paper page
- Hughes A, 2016, State Estimates of Past Year Cocaine Use among Young Adults: 2014 and 2015
- 10.1038/nrendo.2009.48 · DOI · Paper page
- 10.1002/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5 · doi:10.1002/(sici)1096-9861(19990111)403:2<261::aid-cne8>3.0.co;2-5
- 10.1152/ajpendo.00413.2013 · DOI · Paper page
- 10.1523/JNEUROSCI.0115-14.2014 · DOI · Paper page
- 10.1016/j.yfrne.2009.10.004 · DOI · Paper page
- 10.1152/jn.00658.2003 · DOI · Paper page
- 10.1126/science.278.5335.66 · DOI · Paper page
- 10.1101/cshperspect.a012880 · DOI · Paper page
- 10.1016/j.molmet.2015.01.010 · DOI · Paper page
- 10.1111/j.1749-6632.2009.05144.x · DOI · Paper page
- 10.1016/j.ejphar.2005.09.068 · DOI · Paper page
- 10.1371/journal.pone.0061965 · DOI · Paper page
- 10.1097/HCR.0000000000000112 · DOI
- 10.1016/j.physbeh.2015.06.013 · DOI · Paper page
- 10.1111/adb.12295 · DOI · Paper page
- 10.1016/j.neuropharm.2008.06.028 · DOI
- 10.1523/JNEUROSCI.18-01-00488.1998 · DOI · Paper page
- 10.1124/jpet.301.3.1119 · DOI
Cited by
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259
“…laterodorsal tegmental nucleus suppressed operant responding during reinstatement paradigms thought to reflect cocaine seeking; that is, reinstatement of lever pressing was induced by cocaine injections or cues previously associated with cocaine reinforcement (Hernandez et al., 2018, 2019, 2020).”
BackgroundZhang, Y., Kahng, M. W., Elkind, J. A., Weir, V. R., Hernandez, N. S., Stein, L. M., & Schmidt, H. D. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0531-4 · Cited by 92
Self-citationJerlhag, E. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1063033 · Cited by 80
“Thus, in male rats, intravenous cocaine self-administration (Sorensen et al., 2015; Fortin and Roitman, 2017; Hernandez et al., 2019) and the reinstatement of cocaine-seeking (Hernandez et al.”
BackgroundInfluentialAngarita, G. A., Matuskey, D., Pittman, B., Costeines, J. L., Potenza, M. N., Jastreboff, A. M., Schmidt, H. D., & Malison, R. T. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108614 · Cited by 75
Self-citationBornebusch, A. B., Fink-Jensen, A., Wörtwein, G., Seeley, R. J., & Thomsen, M. (2019) · eneuro · doi:10.1523/eneuro.0443-18.2019 · Cited by 72
Douton, J. E., Horvath, N., Mills‐Huffnagle, S., Nyland, J. E., Hajnal, A., & Grigson, P. S. (2022) · Addiction Biology · doi:10.1111/adb.13117 · Cited by 54
“accumbens and the ventral tegmental area to reduce drug-associated behaviours.(18,38) The kinetics of the drug and the design of the experiment then might provide an explanation for the contrasting effects”
BackgroundAlcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1
Jerlhag, E. (2020) · Brain Research · doi:10.1016/j.brainres.2019.146562 · Cited by 53
Chen, X.-Y., Chen, L., Yang, W., & Xie, A.-M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.793004 · Cited by 52
The emerging role of glucagon-like peptide 1 in binge eating
Balantekin, K. N., Kretz, M. J., & Mietlicki-Baase, E. G. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0405 · Cited by 38
Metadata
- Authors
- Hernandez, N. S., O'Donovan, B., Ortinski, P. I., & Schmidt, H. D.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2017-12-11
- Volume
- 24
- Issue
- 2
- Pages
- 170-181
- ISSN
- 1355-6215 (ISSN-L)
- 1369-1600
- OpenAlex
- W2773681276
- Cited by
- 79
- References
- 14
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- National Institute on Drug Abuse (DA031747, DA037897, DA041513)
- National Institutes of Health (R01 DA041513, K01 DA031747, R01 DA037897)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.